Also, Endostar can exert its anti-tumor effect via suppressing b-FGF-induced angiogenesis and b-FGF-activated MAPK signaling pathway, suggesting that Endostar might be a useful agent for treatment of malignant tumors [11]. Here, FGF2 is linked to neoplasm.